Although several studies have demonstrated an association between the 7-repeat (7R) allele in the 48-bp variable number of tandem repeats (VNTRs) in the exon 3 at dopamine receptor D4 (DRD4) gene and attention-deficit/hyperactivity disorder (ADHD), others failed to replicate this finding. In this study, a total of 786 individuals with ADHD were genotyped for DRD4 exon 3 VNTR. All 7R homozygous subjects were selected for VNTR re-sequencing. Subjects homozygous for the 4R allele were selected paired by age, ancestry and disorder subtypes in order to have a sample as homogeneous as possible with 7R/7R individuals. Using these criteria, 103 individuals (66 with ADHD and 37 control individuals) were further investigated. An excess of rare variants were observed in the 7R alleles of ADHD patient when compared with controls (P = 0.031). This difference was not observed in 4R allele. Furthermore, nucleotide changes that predict synonymous and non-synonymous substitutions were more common in the 7R sample (P = 0.008 for total substitutions and P = 0.043 for non-synonymous substitutions). In silico prediction of structural/functional alterations caused by these variants have also been observed. Our findings suggest that not only repeat length but also DNA sequence should be assessed to better understand the role of DRD4 exon 3 VNTR in ADHD genetic susceptibility.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common child and adolescent psychiatric disorders, affecting about 5% of children worldwide. 1 The behavioral symptoms of ADHD load onto two different but correlated dimensions reflecting inappropriate and impairing levels of respectively inattention and hyperactivity/impulsivity. Although its etiology remains unclear, there is strong evidence supporting the role of genes in the disorder. Its heritability has been estimated in 76%. 2 Despite the strong heritability, no major gene effects have been discovered; rather it is likely that several genetic variants, each with small effects, determine together the risk of developing the disorder.
The dopamine receptor D4 (DRD4) gene is one of the most studied potential susceptibility genes for the disorder, mainly a 48-bp variable number of tandem repeat (VNTR) polymorphism in the third exon. This polymorphism can vary from 2 to 11 repeats (2R-11R), being the 4R (65.1%), 7R (19.2%) and 2R (8.8%) the most prevalent alleles. 3 Allele variants produce differences in length of the third intracellular loop of the D4 receptor that couples to postsynaptic G-protein effector. Biochemical analysis has demonstrated that the 7R protein, compared with 4R protein, has a threefold blunted ability to reduce forskolin-stimulated cyclic adenosine-3 0 ,5 0 -monophosphate (cAMP) levels. 4 Owing to its low capacity to respond to dopamine, the 7R has been considered as a susceptibility allele for ADHD. The 7R allele may be associated with a sub-sensitive postsynaptic D4 receptor or hypofunctioning of mesolimbic and mesocortical dopamine pathways. 5 Despite the large number of investigations on the role of DRD4 gene in ADHD in the last decade, even with a positive OR in the most recent meta-analyses, 6 the results of association studies are yet mixed. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Several reasons for these controversial findings have been suggested (for example, small sample size, different phenotypic presentations). However, no definitive answer emerged from the literature.
One attractive possibility to explain these mixed findings would be genetic variability. In this regard, single-nucleotide polymorphisms within repeats were also described, composing 35 sequence variants of the 48-bp repeat unit (motifs). They form at least 74 unique different haplotypes. [18] [19] [20] [21] [22] The most common 7R haplotype is designated as 1-2-6-5-2-5-4, and is observed in several populations. 18 Only one study investigated VNTR sequences in ADHD patients. 19 In that study, the prevalence of rare variants was higher in probands than in controls. The excess of rare variants was not observed in a sample of children with autism. 20 The suggested explanation for these results is based on the common disease rare variant hypothesis, 23, 24 instead of the most accepted hypothesis concerning ADHD etiology-the common disease common variant. 24, 25 The common disease rare variant hypothesis assumes that rare variants could be ADHD specific and allelic heterogeneity could have a role on ADHD etiology. It was suggested that any variant different of the ancestral allele 4R (1-2-3-4) might potentially alter biochemistry and consequently phenotype. Therefore, instead of a specific association with the 7R allele, ADHD might be associated with any allelic variant that differed from the ancestral 4R/4R genotype, because these mutations could alter structure or function of the third cytoplasmic loop. 19, 22, 26 The dopamine D4 receptor 48-bp polymorphic region encodes a proline-rich protein domain in the third cytoplasmic loop, putatively interacting with SH3 domain-containing proteins.
27 SH3 domains are found in a great variety of intracellular or membraneassociated proteins, such as adapter proteins, structural proteins, kinases, lipases and GTPases 28 and they are involved in cell-cell communication and signal transduction from the cell surface to the nucleus.
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SH3 domain is characterized as a modular-binding domain for protein-protein interactions and recognizes proline-rich sequence motifs that contain a conserved PxxP (where P is proline and X is any amino acid) core sequence. 30 Dopamine D4 receptor can interact in vitro with adaptor proteins Grb2 and Nck through a large proline-rich SH3-binding domain. 27 Receptor mutants in SH3 upstream and downstream fail to couple functionally to adenylyl cyclase inhibition and undergoes rapid constitutive internalization. These findings suggest that the third intracellular loop is sufficient for maximal binding with Grb2 and Nck and that the repeats themselves are not essential for this interaction but different alleles may have a modulatory effect on the strength of the interaction with SH3 domain-containing proteins. 27 The aims of this study are to answer the following questions: (1) are ADHD individuals more variable than controls in the third exon of DRD4? (2) Can these mutations affect the third loop secondary structure and/or SH3 signaling?
Subjects and methods

Subjects
The total sample included 786 ADHD individuals. The sample was composed by 378 referred children with ADHD recruited at the Child and Adolescent Psychiatric Division of the Hospital de Clínicas de Porto Alegre (HCPA), and 308 adults with ADHD recruited at the adult clinic in the same hospital. An ADHD consensus diagnosis based on Diagnostic and Statistical Manual of Mental Disorders-IV criteria was achieved through an extensive approach including both clinical interviews and application of semistructured instruments as described in detail previously. 17, 31 The third source was a community sample including 100 children with ADHD inattentive type ascertained from 12 public schools. An extensive diagnostic process based in Diagnostic and Statistical Manual of Mental Disorders-IV criteria and similar to the one used in the samples described above was also implemented in this sample and was fully detailed elsewhere. 32 A total of 330 non-ADHD controls (230 adult blood donors and 100 children) were also included. All 7R homozygous subjects were selected for VNTR sequencing. The 4R homozygotes were selected paired by age, ancestry and disorder subtypes, in order to have a sample as homogeneous as possible with the one including the 7R/7R individuals. Using these criteria, 103 individuals (66 ADHD and 37 control individuals) were further investigated. This sample comes from a population of essentially European ancestry with little evidence of African or Native American admixture. 33 The ethics committee of HCPA approved the study protocol. All subjects (patients and controls) signed an informed consent. For the children, parents provided written informed consent and probands provided verbal assent to participate.
Laboratory methods DNA was extracted from whole blood by a salting out procedure. 34 The 48-bp VNTR in DRD4 exon III was genotyped as previously described. 3, 22 The PCR product was purified with exonuclease I (Exo) and shrimp alkaline phosphatase treatment before sequencing as reported. 18 The primers used for sequencing were D4-3 (5 0 -GCGACTACGTGGTCTACTCG-3 0 ) and D4-J3 (5 0 -CCTTC CCCCACGCCA-3 0 ) described by Lichter et al. 22 When new mutations were observed or when sequences were dubious, the samples were resequenced through independent PCR products.
Analysis of sequence data
In this study, the term 'motif' refers to a variant sequence of the VNTR 48-bp repeat unit. A haplotype means a specific motif composition, and allele refers to a specific length variant. Sequence analyses were accomplished using CodonCode Aligner v3.0.1 DRD4 rare variants in ADHD L Tovo-Rodrigues et al software (Codon Code Corporation, Dedham, MA, USA). Haplotypes were estimated using a Bayesian method implemented in PHASE2.1 software. 35, 36 The haplotypes were derived according to the motifs and point mutations as described previously. 18 Detection of potential functional sites in the deduced amino acid sequences In order to verify possible alterations in secondary structure of the loop caused by mutations, inferred variant amino acids sequences were submitted to Psipred 37, 38 
Statistical analyses
Allele distributions were compared using Fisher's exact test, and the comparisons of molecular substitutions were performed using Kruskal-Wallis test. All tests were two-tailed and significance level was set at 0.05. The analyses were performed with the SPSS software, version 16 (SPSS, www.spss.com, IBM, USA).
Results
DNA sequence analyses of the 206 alleles obtained from Brazilian ADHD probands and controls identified 17 different haplotypes (Table 1 ; Supplementary files). At the 4R allele 6 variable sites were observed whereas 31 different sites were found at the 7R. Three new VNTR motifs were observed, all with new mutations (Figure 1 ). These repeats were called 36, 37 and 38 in accordance to the nomenclature proposed by Ding et al. 18 The divergence among them and motif 2 consists of five nucleotide changes. Moreover, five haplotypes not previously described were also observed (Table 1) . New repeats were identified in three haplotypes being one in a 4R allele and two in the 7R. All of them were observed in ADHD patients. Table 2 shows the diplotypes identified in carriers of the new haplotypes observed in this study. All new haplotypes were in heterozygosis with the most common haplotype.
As expected, the worldwide most frequent haplotypes 4R (1-2-3-4) and 7R (1-2-6-5-2-5-4) were also the most frequent in Brazilians. These haplotypes accounted for 91 and 85% of the chromosomes investigated, respectively. Rare variants were more frequent in ADHD subjects than in controls. Neither controls nor ADHD group showed private rare variants. The 4R distribution did not differ between groups (P = 0.086) while an excess of 7R rare haplotypes were observed in ADHD subjects (P = 0.031; Table 1 ).
When the sequences obtained in this study were pooled with those previously described, most of them (80%) derived from individuals of European ancestry, [18] [19] [20] 22 the same pattern was observed. The 4R variability did not differ between ADHD cases and controls (P = 0.149), but the 7R haplotype distribution was more variable in ADHD patients (P = 0.01; Table 1 ). When nucleotide changes that predict synonymous and non-synonymous substitutions were compared, it was observed that the 7R ADHD group presented more variability for both total substitutions (P = 0.008) and non-synonymous substitutions (P = 0.043; Table 3 ). These differences were not observed for 4R alleles. To verify non-synonymous mutations properties, protein sequences alignments for 4R and 7R alleles were analyzed (Figure 2) .
A fundamental principle that governs the sequence-structure relation of proteins states that the native structure of a protein is determined by its amino acid sequence. 43 As described by Lichter et al., 22 the most frequent mutations are substitutions involving Gly and Pro residues involved respectively with flexibility and rigidity of protein structure. Mutations in haplotypes also appear to change Novel motifs observed in this sample. Published data compiled. [18] [19] [20] 22 These sequences have been deposited in the GenBank database (accession nos. HM191418-HM191434).
DRD4 rare variants in ADHD
L Tovo-Rodrigues et al characteristics like polarity and charge of amino acids residues. Once drastic amino acids substitutions were seen in the rare variants that could potentially alter the protein secondary structure, all polypeptide sequences were submitted to secondary structure predictors. Although drastic, none of the studied mutations appear to change secondary structure. All the sequences were predicted as coil. Three different protein interaction predictors were accessed to verify possible effects caused by the mutations observed. Thirteen SH3 ligand sites were detected in 4R (1-2-3-4) and 25 in 7R (1-2-6-5-2-5-4). These results showed that the 4R variants did not cause any change in SH3 site number. However, some 7R haplotypes ( 
Discussion
In this study, we focused on the DRD4 VNTR exon 3 haplotypes variability in ADHD subjects. Our findings suggest an association between ADHD and DRD4 rare variants.
We documented that the majority of 4R and 7R alleles in ADHD and in control individuals were the worldwide common 4R (1-2-3-4) and 7R (1-2-6-5-2-5-4) haplotypes previously reported. [18] [19] [20] [21] [22] We uncovered a high prevalence (29%) of novel haplotypes. Almost 10% of ADHD individuals had one new rare allele whereas no new variants were observed in the controls. When only 7R allele is considered, 16% of 7R/7R ADHD individuals had one new rare variant, again no new variants were detected in the controls. These figures are similar to those reported by Grady et al. 19 and reinforce findings about variability pattern defined for allele length. Furthermore, the ADHD sample showed more rare variants than controls in the 7R category. Non-synonymous and total substitutions frequencies for 7R allele were also higher in ADHD subjects.
The 7R variability described here corroborate previous findings from the single 7R variability study in the ADHD literature 19 and are better explained by a rare variant-common disease model as suggested previously. 19, 20 Therefore, allelic heterogeneity might also have a role in the association of the DRD4 gene and ADHD. The role of rare variants rather than common variants in common diseases has been addressed in several recent investigations. 'Synthetic' 
New haplotypes are in bold. Table 3 Average number of total and non-synonymous substitution per allele in both case and control groups Abbreviation: ADHD, attention-deficit/hyperactivity disorder. The substitutions were enumerated in comparison with 1-2-6-5-2-5-4 haplotype, the most common haplotype worldwide.
DRD4 rare variants in ADHD L Tovo-Rodrigues et al signals of association could emerge because of a large proportion of genomic regions that harbor one or more rare variants that contribute to disease. 44, 45 It is well characterized that DRD4 protein variants containing different VNTR lengths exhibit different biochemical properties, 4 however, little is known about the effect of amino acid sequence on these differences. These mutations might affect signal transduction by altering interactions with G-proteins or other intracellular effectors that mediate postsynaptic effects. 19, 22 However, no study has addressed this subject yet.
In an attempt to understand mutational effects on D4 receptor, it is important to consider that the VNTR is located in a cytoplasmic loop, where the organization of hydrophobic and hydrophilic residues is very important because of the solvent exposure and their interaction with other proteins or plasmatic membrane. Other important finding is that the DRD4 VNTR region appears to be in a disordered protein region. 46 These regions are characterized as sequences in protein that lack regular secondary structure combined with a high degree of flexibility in the polypeptide strand and appear to have an important role in molecular recognition and signaling. 47 In the predicted polypeptide alignments, it was possible to verify that many of the observed changes are quite dramatic. Changes like that are known to change secondary structure, altering solvent exposure and interactions between proteins. [48] [49] [50] However, no mutation seemed to induce conformational alterations in the third cytoplasmic loop. The coil structure was maintained in all rare variants. SH3-binding domains are involved in signal transduction mainly acting in multiprotein complexes formation. The classical structure of SH3 ligandbinding site consists of two hydrophobic pockets and one negatively charged pocket (specificity pocket). Each one of these hydrophobic pockets accommodates one of the PxxP proline residues of the binding site motif. 30 Our results suggest that mutations could have functional effects to suppress and create SH3-binding sites on the 7R allele. Although considering the well-established pattern of interaction in SH3-binding sites and the greater conservation of SH3 motifs in disordered regions than those in ordered protein regions, 51 it is possible that mutations involving polar/nonpolar residues could interfere in interaction properties. Therefore, it is possible that an integrative effect between allele size and haplotype mutations could be acting on DRD4 ADHD susceptibility.
The interpretation of the present findings must be considered in the context of some limitations. Our whole sample is of moderate size, but the number of ADHD 7R subsample is higher than the one previously investigated. 19 More studies, including larger ADHD and population samples, could help to refine the number and frequency distribution of rare DRD4 alleles. Second, the three novel motifs found could be artifacts. However, samples in which they were observed were re-sequenced through different PCR products to confirm mutations. Finally, it is impossible to know whether rare variants are functionally equivalent/related to 7R alleles without further biochemical/physiological/behavioral experimentation because of the poor understanding concerning SH3-binding sites function in repeat regions. Our result suggests that 7R rare variants could be more deleterious and that alterations are more likely to modify SH3-binding sites in the third cytoplasmic loop rather than its structure. However, these findings should be interpreted with caution because it is an in silico prediction of a static view of a physiological event. Studies of molecular dynamics involving rare variants are needed to better understand the phenomenon, mainly because the VNTR is an intrinsically disordered region. 46 Although a recent study with 48 ancestry informative markers did not show significant population structure in southern Brazilians, 33 no genomic control was performed, therefore our findings could have been biased by hidden genetic heterogeneity present in our specific sample of the southern Brazilian population.
In conclusion, this study found new evidence suggesting a role of DRD4 exon 3 VNTR rare variants in ADHD genetic susceptibility. Therefore, present results provide additional support for the hypothesis that allelic heterogeneity at the DRD4 VNTR is having a role in the association of this gene and ADHD. It is possible to speculate that previous studies reporting on the DRD4/ADHD association modestly underestimated the relative risk by only examining repeat length rather than DNA sequence.
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